tiprankstipranks

Robert Barrow Insider Profile

4 Followers
Robert Barrow, CEO, Director at Mind Medicine, holds 545.77K shares in Mind Medicine (Ticker: MNMD).
tipranks
Robert Barrow

Robert Barrow
Mind Medicine (MNMD)
CEO, Director

Not Ranked
Robert Barrow has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
100.00%
A breakdown of Robert Barrow's holdings

Insider Roles

Mind Medicine
(MNMD)
CEO, Director
Roles that Robert Barrow holds in companies

Most Profitable Insider Trade

Stock:
Mind Medicine
(MNMD)
Rating:Informative Buy
Date:Aug 20, 2024 - Today
Return:+37.60%
The most profitable trade made by Robert Barrow

Robert Barrow's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Mind Medicine
Sep 25, 2024
CEO, Director
Uninformative Sell
118.23K
$3.87M
Success Rate for
MNMD
1 out of 1 profitable transactions on
MNMD
100%
Average Return for
MNMD
Average return per transaction on
MNMD
+37.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Aug 20, 2024
Informative Buy
$6.21K
-
$6.21
+37.60%
Jun 25, 2024
Uninformative Sell
$113.06K
-
$7.22
Sep 25, 2024
Uninformative Sell
$118.23K
-
$5.98
List of latest transactions for each holding click on a transaction to see Robert Barrow's performance on stock

Robert Barrow insider profile FAQ

What is the percentage of profitable transactions made by Robert Barrow?
The percentage of profitable transactions made by Robert Barrow is ―.
    What is the average return per transaction made by Robert Barrow?
    The average return per transaction made by Robert Barrow is ―.
      What stocks does Robert Barrow hold?
      Robert Barrow holds: MNMD stocks.
        What was Robert Barrow’s latest transaction?
        Robert Barrow latest transaction was an Uninformative Sell of $118.23K.
          What was Robert Barrow's most profitable transaction?
          Robert Barrow’s most profitable transaction was an Informative Buy of MNMD stock on August 20, 2024. The return on the trade was 37.60%.
            What is Robert Barrow's role in Mind Medicine?
            Robert Barrow's role in Mind Medicine is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.